SCHEMBL105486

Kakonein is a lipid of Polyketides (PK) class. Kakonein is associated with abnormalities such as Fatty Liver, Chronic liver disease, Morphologically altered structure, Hypertensive disease and Cardiovascular Diseases. The involved functions are known as protein expression, Extravasation, Liver damage, mRNA Expression and cell activation. Kakonein often locates in Body tissue, Hepatic, Microvilli, Cytoplasm and Membrane. The associated genes with Kakonein are TJP1 gene, CD14 gene, iberiotoxin, AT-Rich Interactive Domain-Containing Protein 1A and NKS1 gene. The related lipids are dehydrosoyasaponin I and Steroids. The related experimental models are Knock-out.

Cross Reference

Introduction

To understand associated biological information of SCHEMBL105486, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with SCHEMBL105486?

SCHEMBL105486 is suspected in Chronic liver disease, Hypertensive disease, Cardiovascular Diseases, Myocardial Infarction, Cerebrovascular accident, Fatty Liver and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with SCHEMBL105486

MeSH term MeSH ID Detail
Amnesia D000647 12 associated lipids
Alzheimer Disease D000544 76 associated lipids
Adenocarcinoma D000230 166 associated lipids
Per page 10 20 50 | Total 43

PubChem Associated disorders and diseases

What pathways are associated with SCHEMBL105486

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with SCHEMBL105486?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with SCHEMBL105486?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with SCHEMBL105486?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with SCHEMBL105486?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with SCHEMBL105486?

Knock-out

Knock-out are used in the study 'MATE2 mediates vacuolar sequestration of flavonoid glycosides and glycoside malonates in Medicago truncatula.' (Zhao J et al., 2011).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with SCHEMBL105486

Download all related citations
Per page 10 20 50 100 | Total 919
Authors Title Published Journal PubMed Link
Tiyasatkulkovit W et al. Pueraria mirifica extract and puerarin enhance proliferation and expression of alkaline phosphatase and type I collagen in primary baboon osteoblasts. 2014 Phytomedicine pmid:25442257
Xu YC et al. Structure-activity relationships of flavonoids for vascular relaxation in porcine coronary artery. 2007 Phytochemistry pmid:17395220
Chang Q et al. Simultaneous determination of ten active components in traditional Chinese medicinal products containing both Gegen (Pueraria lobata) and Danshen (Salvia miltiorrhiza) by high-performance liquid chromatography. Phytochem Anal pmid:18438756
Zhao C et al. Rapid simultaneous determination of major isoflavones of Pueraria lobata and discriminative analysis of its geographical origins by principal component analysis. 2011 Nov-Dec Phytochem Anal pmid:21495105
Wu Y et al. Optimisation of ultrasound-assisted extraction of puerarin and total isoflavones from Puerariae Lobatae Radix (Pueraria lobata (Wild.) Ohwi) with response surface methodology. 2012 Sep-Oct Phytochem Anal pmid:22259187
Nguyen VD et al. Identification of a naturally-occurring 8-[alpha-D-glucopyranosyl-(1-->6)-beta-D-glucopyranosyl]daidzein from cultivated kudzu root. Phytochem Anal pmid:19609885
Matkowski A et al. Flavonoids of Pueraria lobata: chromatographic analysis of leaves and roots of cultivated plants. 2003 Pharmazie pmid:14531473
Hu Y et al. Inhibitory effect of puerarin on vascular smooth muscle cells proliferation induced by oxidised low-density lipoprotein via suppressing ERK 1/2 phosphorylation and PCNA expression. 2016 Pharmazie pmid:27004373
Wu CJ et al. Promoting effect of borneol on the permeability of puerarin eye drops and timolol maleate eye drops through the cornea in vitro. 2006 Pharmazie pmid:17020156
Liu XJ et al. The effects of genistein and puerarin on the activation of nuclear factor-kappaB and the production of tumor necrosis factor-alpha in asthma patients. 2010 Pharmazie pmid:20225658
Guo YJ et al. In vivo inhibitory effects of puerarin on selected rat cytochrome P450 isoenzymes. 2014 Pharmazie pmid:24855829
Hu W et al. Puerarin inhibits adhesion molecule expression in tnf-alpha-stimulated human endothelial cells via modulation of the nuclear factor kappaB pathway. 2010 Pharmacology pmid:20016245
Wang L et al. Puerarin Attenuates Osteoarthritis via Upregulating AMP-Activated Protein Kinase/Proliferator-Activated Receptor-γ Coactivator-1 Signaling Pathway in Osteoarthritis Rats. 2018 Pharmacology pmid:29961054
Overstreet DH et al. NPI-031G (puerarin) reduces anxiogenic effects of alcohol withdrawal or benzodiazepine inverse or 5-HT2C agonists. 2003 Pharmacol. Biochem. Behav. pmid:12895679
Rezvani AH et al. Plant derivatives in the treatment of alcohol dependency. 2003 Pharmacol. Biochem. Behav. pmid:12895677
Ji L et al. Puerarin inhibits the inflammatory response in atherosclerosis via modulation of the NF-κB pathway in a rabbit model. 2016 Pharmacol Rep pmid:27505855
Hu W et al. Puerarin inhibits iNOS, COX-2 and CRP expression via suppression of NF-κB activation in LPS-induced RAW264.7 macrophage cells. 2011 Pharmacol Rep pmid:21857089
Liu Q et al. MDR1 and OAT1/OAT3 mediate the drug-drug interaction between puerarin and methotrexate. 2014 Pharm. Res. pmid:24242937
Li Y et al. Comparative physicochemical characterization of phospholipids complex of puerarin formulated by conventional and supercritical methods. 2008 Pharm. Res. pmid:17828444
Gu L et al. Polyamidomine dendrimers: an excellent drug carrier for improving the solubility and bioavailability of puerarin. 2013 Sep-Oct Pharm Dev Technol pmid:22303809
Zhou A et al. Lymphatic transport of puerarin occurs after oral administration of different lipid-based formulations to unconscious lymph duct-cannulated rats. 2014 Pharm Dev Technol pmid:23978005
Yue PF et al. Preparation, characterization, and pharmacokinetic evaluation of puerarin submicron emulsion. 2008 Jan-Feb PDA J Pharm Sci Technol pmid:18402366
Dong-Qin Q et al. Formulation development and pharmacokinetics of puerarin self-emulsifying drug delivery systems. 2007 Jan-Feb PDA J Pharm Sci Technol pmid:17390702
Derda M et al. Plant extracts as natural amoebicidal agents. 2009 Parasitol. Res. pmid:19050923
Hou B et al. Puerarin Mitigates Diabetic Hepatic Steatosis and Fibrosis by Inhibiting TGF- Signaling Pathway Activation in Type 2 Diabetic Rats. 2018 Oxid Med Cell Longev pmid:30057680
Wong R and Rabie B Effect of puerarin on bone formation. 2007 Osteoarthr. Cartil. pmid:17379543
Wong RW and Rabie AB Effect of quercetin on preosteoblasts and bone defects. 2008 Open Orthop J pmid:19461927
Wong RW and Rabie AB Effect of bio-oss collagen and collagen matrix on bone formation. 2010 Open Biomed Eng J pmid:20461225
Liu X et al. Puerarin Inhibits Proliferation and Induces Apoptosis by Upregulation of miR-16 in Bladder Cancer Cell Line T24. 2018 Oncol. Res. pmid:29422113
Hu Y et al. Puerarin inhibits non-small cell lung cancer cell growth via the induction of apoptosis. 2018 Oncol. Rep. pmid:29393465
Lipovac M et al. Effect of Red Clover Isoflavones over Skin, Appendages, and Mucosal Status in Postmenopausal Women. 2011 Obstet Gynecol Int pmid:22135679
Jung HW et al. The Root Extract of Pueraria lobata and Its Main Compound, Puerarin, Prevent Obesity by Increasing the Energy Metabolism in Skeletal Muscle. 2017 Nutrients pmid:28054981
Franke AA et al. Determinants for urinary and plasma isoflavones in humans after soy intake. 2004 Nutr Cancer pmid:15623460
Wan H et al. Protective effect of chuanxiongzine-puerarin in a rat model of transient middle cerebral artery occlusion-induced focal cerebral ischemia. 2008 Nucl Med Commun pmid:18987534
Zhao SS et al. Puerarin attenuates learning and memory impairments and inhibits oxidative stress in STZ-induced SAD mice. 2015 Neurotoxicology pmid:26511841
Li C et al. Puerarin induces the upregulation of glutathione levels and nuclear translocation of Nrf2 through PI3K/Akt/GSK-3β signaling events in PC12 cells exposed to lead. Neurotoxicol Teratol pmid:25195717
Xiong N et al. hVMAT2: A Target of Individualized Medication for Parkinson's Disease. 2016 Neurotherapeutics pmid:27137201
Zhang X et al. Puerarin protects dopaminergic neurons in Parkinson's disease models. 2014 Neuroscience pmid:25218963
Bo J et al. Protection by puerarin against MPP+-induced neurotoxicity in PC12 cells mediated by inhibiting mitochondrial dysfunction and caspase-3-like activation. 2005 Neurosci. Res. pmid:16112764
Cheng YF et al. Involvement of ubiquitin proteasome system in protective mechanisms of Puerarin to MPP(+)-elicited apoptosis. 2009 Neurosci. Res. pmid:19022306
Wang G et al. Implication of the c-Jun-NH2-terminal kinase pathway in the neuroprotective effect of puerarin against 1-methyl-4-phenylpyridinium (MPP+)-induced apoptosis in PC-12 cells. 2011 Neurosci. Lett. pmid:20934486
Tian F et al. The neuroprotective mechanism of puerarin in the treatment of acute spinal ischemia-reperfusion injury is linked to cyclin-dependent kinase 5. 2015 Neurosci. Lett. pmid:25301568
Tian F et al. The neuroprotective mechanism of puerarin treatment of acute spinal cord injury in rats. 2013 Neurosci. Lett. pmid:23570727
Hongyun H et al. Puerarin provides a neuroprotection against transient cerebral ischemia by attenuating autophagy at the ischemic penumbra in neurons but not in astrocytes. 2017 Neurosci. Lett. pmid:28192195
Wang N et al. Puerarin protected the brain from cerebral ischemia injury via astrocyte apoptosis inhibition. 2014 Neuropharmacology pmid:24333675
Zhong Y et al. Puerarin alleviate radicular pain from lumbar disc herniation by inhibiting ERK-dependent spinal microglia activation. 2018 Neuropeptides pmid:30466510
Gao L et al. Puerarin protects against ischemic brain injury in a rat model of transient focal ischemia. 2009 Neurol. Res. pmid:19508827
Wang C et al. Puerarin protects against β-amyloid-induced microglia apoptosis via a PI3K-dependent signaling pathway. 2014 Neurochem. Res. pmid:25173404
Li X et al. Puerarin and Amlodipine Improvement of D-Galactose-Induced Impairments of Behaviour and Neurogenesis in Mouse Dentate Gyrus: Correlation with Glucocorticoid Receptor Expression. 2017 Neurochem. Res. pmid:28831640
Mahdy HM et al. Puerarin ameliorates 3-nitropropionic acid-induced neurotoxicity in rats: possible neuromodulation and antioxidant mechanisms. 2014 Neurochem. Res. pmid:24346712